1. D. J. Begley, Peptides and the blood-brain barrier, in: “Handbook of Experimental Pharmacology, vol 103, Physiology and Pharmacology of the Blood-Brain Barrier,” M.W.B. Bradbury, Ed., Springer-Verlag. Berlin (1992).
2. W. A. Banks and A.J. Kastin, Editorial Review: Peptide transport systems for opiates across the blood-brain barrier. Am. J. Physiol. 259:E1 (1990).
3. T.Y. Terasaki, Y. Deguchi, H. Sato, K. Hirai, and A. Tsuji, In vivo transport of a dynorphin-like analgesic peptide, E-2078, through the blood-brain barrier: an application of brain microdialysis. Pharm. Res. 8:815 (1991).
4. W.A. Banks, K.L. Audus, and T.P. Davis, Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogs. Peptides 13:1289 (1992).
5. B.V. Zlokovic, D.J. Begley, M.B. Segal, H. Davson, L.J. Rakic, M.N. Lipovac, D.M. Mitrovic, and R.M. Jankov, Neuropeptide transport mechanisms in the central nervous system, in: “Peptide and Amino Acid Transport Mechanisms in the Central Nervous System,” L.J. Rakic, DJ. Begley, H. Davson, and B.V. Zlokovic, Eds., Stockton Press, New York (1988).